Believe it or not, APHB, I've been watching since last week. But have hesitated because of low cash position on their balance sheet, and glad I did. The public offering announced proves that having near 1+ yr cash on biotechs is always a good rule to follow before trading them. Never touch them if they have risk of surprise cash raising that can hit news anytime due to a low cash situation.
Anyhow, it may have been more prudent to wait for news to price into the stock yet. Maybe too soon after only part of one day to buy it.
Hope you do well, but I'm waiting yet before considering it.
But now that they have a fresh cash raise on books and in the news, I will consider it soon as an oversold opportunity as short term swing trade or quick flip... All depends on what develops after today.
(and if I miss it, oh well, plenty of others)
***Go to my 'Profile' for more information on following me***